Dr. Reddy Laboratories (RDY)

Add to Watchlists Create an Alert
37.32 -0.17  -0.45%   NYSE May 23, 4:59PM BATS Real time Currency in USD

Dr. Reddy Laboratories Revenue Quarterly:

521.48M for Dec. 31, 2012
View Full Chart

Dr. Reddy Laboratories Revenue Quarterly Chart

    Dr. Reddy Laboratories Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 521.48M
    Sept. 30, 2012 543.48M
    June 30, 2012 447.30M
    March 31, 2012 385.35M
    Dec. 31, 2011 522.49M
    Sept. 30, 2011 465.19M
    June 30, 2011 440.21M
    March 31, 2011 451.70M
    Dec. 31, 2010 422.64M
    Sept. 30, 2010 415.18M
    June 30, 2010 362.66M
    March 31, 2010 365.44M
    Dec. 31, 2009 371.96M
    Sept. 30, 2009 382.13M
    June 30, 2009 378.71M
    March 31, 2009 389.47M
    Dec. 31, 2008 379.79M
    Sept. 30, 2008 347.39M
    June 30, 2008 352.05M
       
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    RDY Revenue Quarterly Benchmarks

    Companies
    Mylan 1.631B
    Akorn 73.85M
    Valeant Pharmaceuticals International 1.068B

    RDY Revenue Quarterly Rankings

    Overall 84th percentile
    1208 of 8006
    Sector 86th percentile
    91 of 686 in Healthcare
    Industry 83rd percentile
    11 of 68 in Drug Manufacturers - Specialty & Generic

    RDY Revenue Quarterly Range, Past 5 Years

    Minimum 347.39M Sep 2008
    Maximum 543.48M Sep 2012
    Average 418.14M